Jesus Anampa, Director of Clinical and Translational Breast Cancer Research at Montefiore Einstein Comprehensive Cancer Center, shared a post on LinkedIn:
“Does adjuvant chemotherapy benefit older women with triple-negative breast cancer?
It is a question that physicians frequently encounter in clinics. Our breast cancer team conducted a study about this topic.
Hint: Age is just a number.”
Title: Adjuvant Chemotherapy Outcomes in Older Adults With Nonmetastatic Triple-Negative Breast Cancer
Authors: Jesus D. Anampa, Jorge Avila, Michael Brodsky, Emery Hakim, Samilia Obeng-Gyasi, Alvaro Alvarez, Carolina Bernabe-Ramirez, Xiaonan Xue
Read the Full Article.